In rodent models of pilocarpine-induced epilepsy and cuprizone-induced multiple sclerosis, the deletion of TRPM2 reduced cytokine levels and attenuated inflammasome engagement within murine brain tissue. Here, TRPM2 is linked to epilepsy.